Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 7
Submit an article Journal homepage
357
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?

Francesco MenzellaDepartment of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3950-5789View further author information
ORCID Icon,
Manuela LatorreDepartment of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, Pisa, ItalyView further author information
,
Patrizia RuggieroDepartment of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, ItalyView further author information
,
Diego BagnascoAllergy & Respiratory Diseases, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, ItalyView further author information
&
Enrico HefflerPersonalized Medicine, Asthma and Allergy, Humanitas Research Hospital, Rozzano, ItalyORCID Iconhttps://orcid.org/0000-0002-0492-5663View further author information
ORCID Icon
Pages 601-606 | Received 26 Dec 2018, Accepted 26 Apr 2019, Published online: 27 May 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Francesco Menzella, Matteo Fontana, Carla Galeone, Maria D’Amato, Giorgio Walter Canonica, Giulia Ghidoni, Silvia Capobelli, Chiara Scelfo, Anna Simonazzi, Chiara Catellani, Patrizia Ruggiero & Nicola Facciolongo. (2021) A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM). Journal of Asthma and Allergy 14, pages 1019-1031.
Read now
Francesco Menzella, Giulia Ghidoni, Matteo Fontana, Silvia Capobelli, Francesco Livrieri, Claudia Castagnetti & Nicola Facciolongo. (2021) The role of systemic corticosteroids in severe asthma and new evidence in their management and tapering. Expert Review of Clinical Immunology 17:12, pages 1283-1299.
Read now
Francesco Menzella, Patrizia Ruggiero, Giulia Ghidoni, Matteo Fontana, Diego Bagnasco, Francesco Livrieri, Chiara Scelfo & Nicola Facciolongo. (2020) Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights. Journal of Asthma and Allergy 13, pages 301-313.
Read now

Articles from other publishers (8)

Cesar Fireth Pozo-Beltran, Barbara Elizondo-Villarreal, Fernando Morett-Vera, Victor Gonzalez-Uribe, Roxana Minerva Rodriguez-Romo, Elsy Maureen Navarrete-Rodriguez, Jorge Andres Paniagua-Santos, Jesus Fernando Ledezma-Ortega & Adriana Virginia Briceño-Gamboa. (2023) Severe Asthma Patients: Can We Really Wean Them off of Oral Corticosteroids. Current Treatment Options in Allergy 10:3, pages 215-231.
Crossref
Francesco Menzella. (2023) Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes. Journal of Clinical Medicine 12:4, pages 1546.
Crossref
Jean Bousquet, Bernardo Sousa-Pinto, Francesca Puggioni, Aram Anto, Fabio Balli, Thomas Casale, Wienczyslawa Czarlewski, Anna Bedbrook, Luisa Brussino, Mina Gaga, Bilun Gemicioglu, Ludger Klimek, Violeta Kvedariene, Renaud Louis, Joaquin Sastre, Nicola Scichilone, Arunas Valiulis, Eleptherios Zervas, Arzu Yorgancioglu, Torsten Zuberbier, Josep M Anto, G Walter Canonica & Joao A Fonseca. 2023. Asthma in the 21st Century. Asthma in the 21st Century 231 244 .
Javier Domínguez-Ortega, Julio Delgado Romero, Xavier Muñoz Gall, Amparo Marco & Marina Blanco-Aparicio. (2022) Uso de glucocorticoides sistémicos para el tratamiento del asma grave: Consenso multidisciplinar español. Open Respiratory Archives 4:4, pages 100202.
Crossref
Zeyi Zhang, Jingjing Wang & Ou Chen. (2021) Identification of biomarkers and pathogenesis in severe asthma by coexpression network analysis. BMC Medical Genomics 14:1.
Crossref
Claudia Chaves Loureiro, Manuel Branco Ferreira, Jorge Ferreira, Ricardo Lima, João Marques, Anna Sokolova, Fernanda S. Tonin & Filipa Duarte Ramos. (2021) Reducing oral corticosteroids in severe asthma (ROSA Project): a nationwide Portuguese consensus. Pulmonology 27:4, pages 313-327.
Crossref
Francesco Menzella, Patrizia Ruggiero, Carla Galeone, Chiara Scelfo, Diego Bagnasco & Nicola Facciolongo. (2020) Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma. Pulmonary Pharmacology & Therapeutics 64, pages 101966.
Crossref
Kareem Khalaf, Giovanni Paoletti, Francesca Puggioni, Francesca Racca, Fabrizio De Luca, Veronica Giorgis, Giorgio Walter Canonica & Enrico Heffler. (2019) Asthma from immune pathogenesis to precision medicine. Seminars in Immunology 46, pages 101294.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.